Organigram Holdings Inc. SG&A Expenses

SG&A Expenses of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including SG&A Expenses growth rates and interactive chart. Selling, general and administrative expense (SG&A) is reported on the income statement as the sum of all direct and indirect selling expenses and all general and administrative expenses (G&A) of a company. SG&A, also known as SGA, includes all the costs not directly tied to making a product or performing a service. That is, SG&A includes the costs to sell and deliver products and services and the costs to manage the company. It includes administrative

Highlights and Quick Summary

  • SG&A Expenses for the quarter ending February 28, 2023 was $12.8 Million (a -1.01% decrease compared to previous quarter)
  • Year-over-year quarterly SG&A Expenses decreased by -10.55%
  • Annual SG&A Expenses for 2022 was $50.7 Million (a 22.29% increase from previous year)
  • Annual SG&A Expenses for 2021 was $41.5 Million (a 13.21% increase from previous year)
  • Annual SG&A Expenses for 2020 was $36.6 Million (a 14.64% increase from previous year)
  • Twelve month SG&A Expenses ending February 28, 2023 was $54.2 Million (a 2.17% increase compared to previous quarter)
  • Twelve month trailing SG&A Expenses increased by 12.02% year-over-year
Trailing SG&A Expenses for the last four month:
28 Feb '23 30 Nov '22 31 Aug '22 31 May '22
$54.2 Million $53.1 Million $50.7 Million $48.4 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical SG&A Expenses of Organigram Holdings Inc.

Most recent SG&A Expensesof OGI including historical data for past 10 years.

Interactive Chart of SG&A Expenses of Organigram Holdings Inc.

Organigram Holdings Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $12.82 – – – –
2022 $12.95 $14.12 $14.33 $11.67 $50.72
2021 $10.6 $11.8 $11.44 $9.48 $41.48
2020 $8.76 $8.54 $8.12 $11.62 $36.64
2019 $8.35 $12.17 $8.29 $7.3 $31.96
2018 – – – $4.2 $12.59
2017 – – – – $5.82
2016 – – – – $3.11

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com